Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients (English, HTML)

View metadata and access the original English HTML file: Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients.

Format

HTML

Access

file-only

Publisher-reported update

2023-12-02

Canada’s health care system is complex and involves the participation of multiple stakeholders, who all have distinct roles in the planning and delivery of healthcare services. Health Canada’s decision-making role in approving a drug for marketing is distinct from the roles of those who make decisions about price-setting and public drug plan reimbursements.

Access original file